Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$238K Buy
+5,445
New +$265K 0.29% 78
2022
Q2
Sell
-5,486
Closed -$291K 98
2022
Q1
$291K Buy
5,486
+66
+1% +$3.42K 0.27% 79
2021
Q4
$296K Buy
+5,420
New +$269K 0.22% 92
2020
Q1
Sell
-3,005
Closed -$111K 227
2019
Q4
$111K Buy
3,005
+8
+0.3% +$285 0.1% 155
2019
Q3
$103K Buy
2,997
+8
+0.3% +$291 0.09% 148
2019
Q2
$122K Sell
2,989
-6,041
-67% -$240K 0.11% 142
2019
Q1
$364K Sell
9,030
-1,037
-10% -$41.5K 0.21% 87
2018
Q4
$416K Sell
10,067
-7,826
-44% -$325K 0.28% 73
2018
Q3
$746K Sell
17,893
-23
-0.1% -$885 0.37% 66
2018
Q2
$618K Buy
17,916
+11
+0.1% +$376 0.31% 72
2018
Q1
$603K Buy
17,905
+1,611
+10% +$55.4K 0.32% 67
2017
Q4
$562K Sell
16,294
-5,213
-24% -$178K 0.3% 66
2017
Q3
$726K Sell
21,507
-18,146
-46% -$583K 0.41% 59
2017
Q2
$1.26M Buy
39,653
+36,820
+1,300% +$1.16M 0.78% 39
2017
Q1
$92K Sell
2,833
-1,410
-33% -$44.5K 0.09% 139
2016
Q4
$132K Buy
+4,243
New +$130K 0.14% 106

Other funds holding PFE

Bell Rock Capital's PFE Position: Q3 2022 in Review

Bell Rock Capital opened a new position in Pfizer (PFE) in Q3 2022: 5,445 shares worth $238K. The stake represents 0.29% of the portfolio and ranks #78 among its holdings. This is a return to the name: Bell Rock Capital previously reported a position in PFE as recently as Q1 2022.

Bell Rock Capital first reported a position in PFE in Q4 2016 and has held it in 16 quarters since. The position peaked at $1.26M in Q2 2017. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Bell Rock Capital held 5,445 shares of Pfizer worth $238K as of Q3 2022.
  • Pfizer was a new Bell Rock Capital position in Q3 2022.
  • Pfizer made up 0.29% of Bell Rock Capital's portfolio in Q3 2022, its #78 holding.
  • Bell Rock Capital first reported a position in Pfizer in Q4 2016 and has held it in 16 quarters since.
  • Bell Rock Capital's Pfizer position peaked at $1.26M in Q2 2017.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Bell Rock Capital's 13F filing for Q3 2022, filed 28 Oct 2022.